Sun Pharmaceutical Industries has taken the lead in a fiercely contested race to market with Johnson & Johnson for a new class of psoriasis drug.

Hanmi Pharma gained one big deal with Roche this week but lost another tie-up with Boehringer--and investors didn't like it one bit.

Sun Pharma licensed a home-grown dengue fever vaccine that it hopes will rival Sanofi's Dengvaxia, which was recently delayed in India.

Complicated drug formulations are generally viewed as a barrier to generic competition, but that is not stopping India's Glenmark from placing Celgene…

Japan's Otsuka is hoping that smart packaging could help one of its main pharma products maintain a hold in the marketplace.

Hepatitis C is a big problem in China, and drugmakers are still waiting on approval for their next-gen treatments. Now, regulators are promising action--and…

Government warns drugmakers could leave the UK if the country's separation from the EU drags on and is kept under wraps.

Japan's Oncolys BioPharma wants to muscle in on Amgen's cancer-killing virus for melanoma. The biotech has filed to start trials of its version in U.…

Plans are being laid for India and the U.S. to work together on the development of vaccines for dengue fever and other diseases that pose a major threat to…

R&D